Nevertheless, medicines like warfarin and insulins are critical to be made consistently available to reduce the risk of mortality in post-cardiac surgery and Type I diabetes mellitus (T1DM) patients, respectively, which is an all too frequent problem across LMICs. The gene discussed is INS; the disease is type 1 diabetes mellitus.